EU Starts Approval Process for Russia’s Sputnik V Vaccine
The EU has begun analyzing clinical trial data for Russia’s Sputnik V vaccine — the first step in a process which could lead to the vaccine’s approval for use across the 27-member bloc. The European Medicines Agency (EMA) said Thursday it had begun a so-called “rolling review” of Sputnik V, in which it will analyze…
Details